| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Stream 2: Drug Discovery X-Hubs -New Vision on Drug Discovery Science and Technology |
Substream 2-1: Dynamic Bio X-Hub |
| Substream 2-3: Computer-aided Drug Discovery |
|||
|
Session 2301: Computer-aided Drug Discovery Day 2: Afternoon, Friday, August 17, 2018 Place: Endeavor Room, 3rd Floor 13:30-17:10 |
|||
| Chair: Dr. Zhenhong Li, Senior Principal Scientist, Medicine Design Modeling and Simulation, Pfizer Global Research and Development, USA | |||
|
Co-Chair: Dr. Pavel Pospisil, PMI R&D, Philip Morris Products S.A., Switzerland |
|||
| Time | FaceOn | Speeches and Speakers | |
| 13:30-13:35 | Chair's Introduction | ||
| 13:35-14:00 |  |
Title: Translational ADME and PBPK/PD Sciences to Impact Drug Discovery and Development
|
|
| 14:00-14:25 |  |
Title: Big Data Driven Drug Development Strategy for Alzheimer Disease Dr. Gyungah Jun, Assistant Professor, Boston University School of Medicine, USA |
|
| 14:25-14:50 |  |
Title: A Model-based Assessment of Plasma Citrate Flux into the Liver: Implications for NaCT as a Therapeutic Target Dr. Zhenhong Li, Senior Principal Scientist, Medicine Design Modeling and Simulation, Pfizer Global Research and Development, USA |
|
| 14:50-15:15 |  |
Title: Using DILIsym, A Quantitative Systems Toxicology Modeling Tool of Drug-induced Liver Injury (DILI), to Assess DILI Risk in Drug Development Dr. Brett A. Howell, President, DILIsym Services Inc., a Simulations Plus Company; Associate Director, DILI-sim Initiative, USA |
|
| 15:15-15:30 | Coffee Break | ||
| 15:30-15:55 |  |
Title: Integrated Informatics Platform for Drug R&D Dr. Jinbo Lee, Chief Scientific Officer, Scilligence Corporation, USA |
|
| 15:55-16:20 |  |
Title: Software Tool for Population Pharmacokinetic Analysis and Model Preparation with Usage of Iterative Two-Stage Bayesian Technique Dr. Jiří Douša, Head of Medical Softtware Development Team, Mediware Company, Czech Republic |
|
| 16:20-16:45 |  |
Title: Building an Efficient R & D Chemo-centric Data Repository System that Leads to Knowledge Discovery Dr. Pavel Pospisil, PMI R&D, Philip Morris Products S.A., Switzerland |
|
| 16:45-17:10 |  |
Title: Discovery and Development of Novel Inhibitors of the MDMs Proteins for Cancer Therapy Dr. Valeria La Pietra, Assistant Professor, University of Naples "Federico II", Italy |
|
© 2003-2018 All rights reserved by BITeomics Inc. |